icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Rohrabacher-Blumenauer: What Are The Stakes – Revisited

By J.J. McCoy, Senior Managing Editor for New Frontier Data In what has become a de facto annual event on Capitol Hill (where a version was first proposed in 2001, finally passed in 2014, and renewed each fiscal year since), the Rohrabacher-Blumenauer amendment was again blowing in the wind for the past week amid all the […]
Read more

2 Million Medical Patients Impacted?

  The Rohrabacher-Blumenauer Amendment works to protect medical cannabis programs in 29 states and the District of Columbia. The states most affected by a non-renewal of this amendment would be California, Michigan, and Arizona, as they comprise 70% of the nearly 2 million registered U.S. cannabis patients in the U.S. Support for medical cannabis is […]
Read more

How Final Tax Reforms Impact Your Cannabis Business

By Selvan Boominathan, JD, LLM The Tax Cuts and Jobs Act (TCJA) has become the law of the land, and yet, still no relief for cannabis businesses from Section 280E.  As we wrote in an earlier post, there are still significant tax reductions available to cannabis taxpayers, if you know where to look.  This post […]
Read more

Cannabis Market Recovers after Steep Decline

  Attorney General Jeff Sessions' Jan. 4 announcement rescinding the Cole Memo sparked a steep but short-lived selloff of U.S. cannabis stocks. By January 11th, stocks had rebounded to within 5% of their value before the Cole Memo was rescinded. The 21%, one-day decline was fueled by investors unnerved by implications for the federal government's […]
Read more

WHO to DOJ, re: CBD: It’s All (Medicinally) Good

By J.J. McCoy, Senior Managing Editor for New Frontier Data Newly published findings from the World Health Organization (WHO) about the medicinal benefits of cannabidiol (CBD) fall in direct opposition to the stance of the U.S. federal government’s keeping it listed as a Schedule I controlled substance. Publishing recent findings which directly contradict both the established […]
Read more

2017 CannaBit Highlights

  The top 5 most clicked-on CannaBit topics of 2017 included projections for individual state markets, and how White House politics could affect the cannabis industry. By 2020, Massachusetts’ total cannabis sales are expected to reach $1 billion, with adult-use sales representing 72% of its market. By 2020, Washington’s cannabis market sales are forecast to reach $2 billionas the state […]
Read more

DOJ Rescinds Cole Memo, Raising Stakes for Rohrabacher-Blumenauer Renewal

By J.J. McCoy, Senior Managing Editor for New Frontier Data In a three-paragraph memo released on Thursday, U.S. Attorney General Jeff Sessions rescinded several Obama-era directives which since 2013 had discouraged enforcement of federal marijuana laws in states which had legalized cannabis. Sessions encouraged federal prosecutors to use their own discretion — given the department’s limited [...]
Read more

Sessions’ Rescinding of the Cole Memo to have Chilling Effect on Cannabis Public Markets

January 4, 2018 Washington – Attorney General Jeff Sessions announced that he will rescind “the Cole Memo,” a policy put in place during the Obama Administration which gave guidance to federal prosecutors operating in states where cannabis had been legalized for medical or adult use. New Frontier Data, the authority in business intelligence for the cannabis […]
Read more

53% Unprecedented Growth Rate in Cannabis Cultivation Supply Segment

 New Frontier Data and GrowGeneration Corp. release a first-of-its-kind report examining market insights on cannabis cultivation supplies, brands and products December 20, 2017 Washington – New Frontier Data, the global cannabis industry authority in business intelligence and data analysis reporting, in partnership with GrowGeneration Corp. (OTCQX: GRWG), the largest publicly traded cannabis [...]
Read more

Data Power in Equio

  New Frontier Data's proprietary Equio platform uses millions of data points gathered from government agencies, industry groups, and 100+ cannabis premier industry partners and to provide you the essential data, analysis, and intelligence to strengthen your position in the cannabis industry.  Chose the Equio level best suited to keep you strong in 2018  Equio Essential Designed […]
Read more